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Summary 
To assess the role of immunoglobulin D (IgD) in vivo we generated IgD-deficient mice by gene 
targeting and studied B cell development and function in the absence of IgD expression.  In the 
mutant animals,  conventional and CD5-positive (B1) B cells are present in normal numbers, 
and the expression of the surface markers CD22 and CD23 in the compartment of conventional 
B cells indicates acquisition of a mature phenotype. As in wild-type animals, most of the peripheral 
B cells are resting cells. The IgD-deficient mice respond well to T cell-independent and -dependent 
antigens. However, in heterozygous mutant animals, B cells expressing the wild type IgH locus 
are overrepresented in the peripheral B cell pool, and T cell-dependent IgG1 responses are further 
dominated by B cells expressing the wild-type allele. Similarly, in homozygous mutant (IgD- 
deficient) animals, affinity maturation is delayed in the early primary response compared to control 
animals,  although the mutants are capable of generating high affinity B cell memory. Thus, 
rather than being involved in major regulatory processes as had been suggested, IgD seems to 
function as an antigen receptor optimized for efficient recruitment of B cells into antigen-driven 
responses.  The IgD-mediated acceleration  of affinity  maturation in the early phase of the T 
cell-dependent primary response may confer to the animal a critical  advantage in the defense 
against pathogens. 
I 
gD is the major antigen receptor isotype coexpressed with 
IgM on the surface of most peripheral B cells in mouse, 
humans, and a variety of other species (1-7).  The genes en- 
coding the constant region of the #  (C/~) and the/~ (C/~) 
chain reside in a single transcription unit and can be expressed 
simultaneously, by alternative splicing of the V region exon 
to the first exon of the C/~ or the C/~ gene (8). The regula- 
tion of IgM and IgD expression appears to follow a strict, 
developmentally controlled program. 
Newly arising "immature" B cells in the bone marrow or 
fetal liver express IgM but not IgD on their surface, whereas 
the vast majority of "mature" peripheral B cells of an adult 
mouse is characterized by surface expression of IgM and IgD 
(9, 10). The amount of IgD expressed exceeds that of IgM 
by about 10-fold (11). During ontogeny, the first/~+8+  B 
cells appear about 4 d after birth, and the frequency of these 
cells gradually increases to adult levels by 4-6 wk of age (3, 
4, 12, 13). IgM as well as IgD can mediate B cell activation 
(14), and it seems that both receptors can transduce signals 
by the same mechanism (15). 
Upon activation of B cells by antigen, IgD is downregu- 
lated (16, 17) and the cells enter the pathways of plasma cell 
or memory cell generation (18). The downregulation of IgD 
is accompanied by an increase in IgM expression,  and subse- 
quent secretion of this isotype in the early primary response. 
Since its discovery (19), the biological role of IgD has re- 
mained enigmatic despite continuing experimental effort aimed 
at defining its role in B cell development. Data obtained from 
experiments applying anti-IgD antibodies or proteolytic en- 
zymes in vivo or in vitro were interpreted as evidence for 
an important role of IgD in the transition from a stage of 
susceptibility to tolerance induction to one of responsiveness 
(20-24) or in triggering B cells by particular types of an- 
tigen. However, contradictory results have been reported (13, 
25-30). A distinct function of IgM and IgD was suggested 
by the observation that treatment with anti-IgM but not anti- 
IgD in vitro induced growth arrest  of cell lines or normal 
mature B cells expressing IgM and IgD on the surface (31-33). 
Furthermore, a requirement for surface expression of IgD for 
the propagation of immunological memory has been sug- 
gested (34), but contradictory results were reported (35, 36). 
If, however, IgM and IgD would deliver the same signal (15) 
or would not signal at all but just serve as an antigen-focusing 
device allowing efficient antigen processing and presentation 
(37),  the coexistence of two receptor isotypes might serve 
simply to improve antigen binding (38, 39). A specific role 
for IgD in the interaction between B and T cells, mediated 
by IgD binding receptors expressed on T cells, was proposed 
based on the observation of rosette formation of IgD-coated 
erythrocytes with a subpopulation of T cells (40). The deter- 
45  J. Exp. Mcd. ￿9  The Rockefeller University Press ￿9  0022-1007/93/01/0045/11 $2.00 
Volume 177  January 1993  45-55 minants  recognized by this IgD receptor were reported to 
be sugar residues on the C~1  and C~3 domain  (41). 
An interesting and unexpected phenomenon, with respect 
to expression of IgM and IgD, was observed in mice trans- 
genic for rearranged  H  and L chain genes encoding a self- 
reactive antibody. Autospecific B cells, found to be anergic, 
had dowuregulated surface expression of IgM, whereas the 
level of IgD expression remained high. These data led to the 
suggestion that  IgD may play a role in maintaining  B cell 
tolerance (42). Along these lines, coincidence of low IgD sur- 
face expression and autoreactivity of B cells has been observed 
in some mouse strains prone to the development of autoim- 
mune disease and in the CD5 B cell population  of normal 
mice (43). 
To more directly assess the role of IgD in B cell develop- 
ment, we generated IgD-deficient mice utilizing the gene- 
targeting technique. We have previously shown, in chimeric 
mice, that B cells expressing the IgH allele bearing a non- 
functional C~ gene appear as/z +  ~- B cells in the periphery 
at the same frequency as their counterparts  expressing the 
wild-type allele (#+/~+)  (44). These/~+6-  B cells seemed to 
mature normally and respond to a TD antigen,  ruling out 
an essential role for IgD in the transition from a state of sus- 
ceptibility to tolerance induction  to one of responsiveness. 
Although  the analysis  of chimeric mice established that  B 
cells can develop and respond to antigen without ever having 
expressed IgD, it did not allow for a detailed functional com- 
parison of IgD-expressing and IgD-deficient B cells, nor did 
it exclude a possible biological role of IgD apart from serving 
as a receptor on the surface of the cell producing it (45). There- 
fore, we generated a mouse line deficient for IgD through 
germline transmission of the mutated C~ allele. Results ob- 
tained using this system are reported in the present paper. 
Materials  and Methods 
Gene Targeting.  Gene targeting of the C~ gene was performed 
as described (44) except that the 129/ola-derived embryonic stem 
(ES)  1 cell line E14-1 (46) was used. A total of 10  a E14-1 ES cells 
were transfected with the targeting  vector designed to replace a 
large part of the C61 exon and to insert frameshift mutations  in 
C~3 by filling in restriction  sites present in this exon (44). The 
introduction  of the mutations  into the germline would result in 
functional inactivation of both # chain Ig domain exons. This was 
considered important  to exclude the possibility of expression of a 
truncated 6 H chain that could compete with/~ for L chains and 
be secreted. The presence of the frameshift in the mouse germline 
was indicated by an NheI restriction  site resulting from filling in 
the HindIII site in C~3 (see Fig. 1, c and d, and data not shown). 
The C#2 exon is a pseudoexon due to a nonfunctional  splice ac- 
ceptor (47). Colonies surviving selection were analyzed by PCR, 
and positive clones were further analyzed by Southern blotting to 
confirm the structure  of the targeted locus. Homologous recom- 
binants were obtained at a frequency of 1/17 double-resistant or 
1/103 G418-resistant clones. Targeted ES cell clones were injected 
x Abbreviations used in this I~per: BrdU, bromodeoxyufidine;  CG, chicken 
globulin; ES, embryonic  stem; NP, (4-hydroxy-3-nitrophenyl)acetyl;  PtC, 
phosphatidylcholine. 
into  blastocysts isolated from C57B1/6 mice and transferred to 
(C57B1/6 x BALB/c) fosters. Male chimeric offspring were mated 
with C57B1/6 females for germline transmission of the 6T muta- 
tion. Offspring derived from ES cells were identified by coat color. 
Mice.  Animals were bxed in our own conventional mouse fa- 
cility. 
Southern Blot Analysis.  Southern blot was performed as described 
(48). 
Northern Blot Analysis.  Total  R.NA was isolated from spleens 
using guanidiniumisothiocyanate-containing  lysis buffer with sub- 
sequent CsC1 gradient purification (48). Poly(A) + RNA was en- 
riched using oligo-dT spun columns (Pharmacia Fine Chemicals, 
Freiburg, FRG) size fractionated by formaldehyde agarose gel elec- 
trophoresis as described (48) and transferred to a nylon filter. An 
RNA ladder (Gibco BILL, Eggenstein, FR.G) was included to de- 
termine the sizes of the various RNA species. The probe used for 
hybridization  was a 1-kb C/~ cDNA fragment obtained by PCR 
amplification using J~4- and C/~m-specific primers. This fragment 
was digested with BglII,  cutting in C/~1, to remove the 5'-part 
containing  J~4. The  C#m-specific  probe  was  a  700-bp-long 
HincII/BgllI genomic fragment  including  the ~ml exon, inter- 
vening sequence, ~m2, and a part of the Y-untranshted region 09). 
The neomycin  r (neo) gene was detected with a 1.1-kb XhoI/SalI 
fragment isolated from pMClneo (49), and the C83-specific probe 
was a genomic 1.2-kb NcoI/BglI fragment spanning from the 5' 
end of the C~3 exon through a region of the 3' intron (47). To 
remove probes for sequential hybridization,  filters were stripped 
to background levels of radioactivity by boiling in 0.1x SSC/0.1% 
SDS. 
Flow  Cytometry.  Analyses were performed  on  a  FACScan  | 
cytometer (Becton Dickinson & Co., Mountain  View, CA). The 
reagents and staining procedures have been described (44, 50, 51). 
CD22 was revealed by staining cells with rat mAb NIM-R6 (52) 
superuatant (gift of Dr. R. M. E. Parkhouse, Institute  for Animal 
Health, Pirbright,  UK) and detected with FITC-conjugated mAb 
MarlS.5 (anti-rat X; 53). IgD was revealed using FITC-conjugated 
polyclonal rabbit anti-mouse IgD antiserum (Nordic Immunolog- 
ical Laboratories, Capistrano Beach, CA), and normal rabbit serum 
was used to block nonspecific binding. Phosphatidylcholine (PtC) 
binding cells were detected by staining cell suspensions with FITC- 
loaded PtC liposomes (54; gift of Dr. A. Kantor, Stanford Univer- 
sity Medical Center,  Stanford, CA). 
Analysis ofB Cell Life S~n.  5'-bromo-2'-deoxyuridine  (BrdU; 
Sigma Chemical Co., St. Louis, MO) labeling experiments were 
performed as described (55) except that the concentration  in the 
drinking  water was 1 mg/mL 
Immunization  of Mice.  10, 20, or 100/~g  (4-hydroxy-3-nitro- 
phenyl) acetyl (NP) coupled to chicken gamma-globulin (CG) (NP- 
CG) precipitated in alum/PBS,  50/zg ce(1-3)-dextran (gift of Dr. 
J. Kearuey, University of Alabama, Birmingham,  AL) in PBS or 
5/~g NP-Ficoll in PBS were injected intraperitoneally. 50/~g NP- 
CG in alum were injected intraperitoneally 6 wk after priming to 
elicit a secondary response (see also reference 51). 
Titration ofSerura  Ig.  Serum Ig isotypes IgM, IgG3, IgG2b, 
IgE, and IgA were determined by a direct plate binding assay as 
described (46). IgG1 and IgG2a were determined by direct binding 
to plates coated with  mAb Ig-4a(10.9) (44; anti-IgGP)  or rat 
anti-mouse IgG2a antiserum (Nordic Immunological Laboratories). 
Bound Ig was revealed by biotinylated  goat anti-mouse IgG2a 
(Southern Biotechnology Associates, Birmingham, AL). mAbs of 
the various isotypes served as standards. Antigen-specific titers were 
determined on plates coated with NP14-BSA or CG at 10/~g/ml 
or o~(1-3)-dextran-BSA at 50/~g/ml.  Anti-NP and anti-CG titers 
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for  IgG  isotypes. Concentrations  of  NP-,  CG-,  or  cr 
dextran-specific serum antibodies were quantified relative to NP- 
binding standard antibodies of the various isotypes. 
A.~nity Measurements.  These were done as described (36, 56) 
using microtiter plates coated with NP4-BSA  and NPt4-BSA. Anti- 
NP mAbs of known affinities, from primary and secondary re- 
sponses, served  as standards (56). Bound antibody was revealed  by 
a biotinylated anti-IgGl' (Ig4a-10.9; 44) or anti-M  (LS136; 46) 
mAb. As reported for anti-DNP antibodies (36), we have previ- 
ously shown that the relative binding to coats of high and low 
epitope density correlated  with the log of the affinity  binding con- 
stants of IgG anti-NP antibodies (56; T. Tokuhisa, unpublished 
results). 
Results 
Generation oflgD-deficient Mice.  The strategy of C/~ gene 
inactivation was the same as previously described (44). Re- 
striction maps of wild-type and mutated C/~ loci as well as 
restriction analysis of HindIII-digested genomic DNA from 
five individual candidate recombinants (Fig.  1 a, lanes 2-6) 
and control cells (Fig. 1 a, lane I) are shown. A homologous 
recombination event would result in a 4.4- or 6.0-kb band 
Figure  1.  Southern blot analysis of (a) PCR-positive  E14-1 embryonic 
stem cell clones transfected with the targeting vector; and (b) tail DNA 
of  mice obtained through germline transmission of the mutated C/~ allele. 
Genomic DNA samples were digested with HindlII (a) or BamHI (b), 
respectively. (Bottom) Restriction  maps and the genomic organisation  of 
(c) the C/z/~ locus and (d) the mutated allele. The probe indicated in (c) 
is a XhoI/EcotLV fragment derived from the C/~-/5 intron. (B) BamHI; 
(D) DrallI (not unique);  (E) EcoR.I; (H) HindlII; (X) XhoI; (X*) 5'-end 
of the targeting vector; and (/-F) HindlIl site deleted in the targeting vector 
generating  a frame shift  mutation (44). 
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in addition to the 3.8-kb germline band, depending on the 
presence or absence of the frame shift mutation in C~3 that 
results in loss of the HindlII site (Fig.  1, c and d). 9 of 10 
homologous  recombinant dones showed the 6.0-kb fragment, 
indicating that the breakpoint of recombination was located 
3' of the C~3 exon. Thus, the C/~I and C/~3 exons were ren- 
dered nonfunctional in these clones. One done retained the 
HindlII restriction site in the C_~3 exon, resulting in a diag- 
nostic restriction fragment of 4.4 kb (Fig.  1 a, lane 6). The 
structure of the targeted locus was confirmed using a variety 
of other probes and restriction enzymes (data not shown). 
Four clones harboring mutated C~1 and C/~3 exons were in- 
jected into blastocysts and the resulting male chimeras were 
mated with C57B1/6 females for germline transmission of 
the mutated allele. Offspring derived from ES cells were 
identified by coat color and analyzed for the presence of the 
mutation which we call 6T, by Southern blotting (Fig. 1 b) 
or phenotypically, by flow cytometry. Homozygous mutant 
mice (/~T//~T) were obtained by the interbreeding of hetero- 
zygous offspring (Fig.  1 b, lanes 5 and 6). 
raRNA Potentially Able to Encode an IgD-like Molecule Is 
Undetectable in Homozygous Mutant Mice by Northern Blot Anal- 
ysis.  The ~T mutation results in functional inactivation of 
both exons encoding Ig domains of the H chain. The trans- 
membrane and the hinge region exons, however, remain in- 
tact  and  potentially functional.  To  exclude  that  aberrant 
splicing of precursor RNA encompassing both the C/z and 
the C~ genes results in the generation of a significant amount 
of chimeric Ig transcripts  encoding the extracellular domains 
of the C/z gene and the transmembrane and cytoplasmic por- 
tion  of C~,  we  analyzed  poly(A) +  tLNA  isolated  from 
spleens of homozygous mutant (/~T//ST) and wild-type mice 
by Northern blotting (Fig. 2). mRNA containing C/z exons 
spliced to the C/~ transmembrane exon would be larger than 
the normal C/~ transcripts of 2.4 (/zs) or 2.7 kb (/zm) (57), 
because the 3'-untranslated region of the # message is 600-bp 
longer than that of the #  message (39).  Hybridization of 
splenic poly(A) + RNA of homozygous mutant mice with 
a C~ transmembrane-specific probe reveals  bands of 4.8-, 4.0-, 
3.8-, and 3.0-kb. However,  none of these bands hybridized 
with the C/z-spedfic probe (Fig. 2, A and B). The detection 
limit of the two probes was similar within a factor of two 
(1.2  x  106 copies  for the C/z  and 0.6  x  106 for the/~m 
probe) as judged by the signals obtained from hybridization 
to standard plasmid DNA (data not shown). The C/~ probe 
is a eDNA fragment of I  kb with complete match to the 
mRNA and the standard plasmid, whereas the ~m probe hy- 
bridizes to the mRNA over a stretch of only 480 bp, but 
700 bp on the plasmid standard because it contains the ~3ml/m2 
intron. Consequently, a mRNA representing C/z exons spliced 
to the 6m exons, if detected with the ~m probe, should also 
be revealed with the C/~ probe. Because the 3.0-, 3.8-, 4.0-, 
and 4.8-kb bands are clearly above the 6m probe detection 
limit, they should, if containing C/~ sequences, also be de- 
tected with the C~ probe. This, however, is not the case (Fig. 
2 B, lanes a and b;  right). 
Furthermore, sequential hybridization of the same blot 
with  a  neo' gene and  a  probe  specific for  the  C83 exon |gH~.6T/~IH~,§  IgH~,~T/Iga~,~T 
8"32:  :~,:  I=i  :2~  '  ~  12.8  21.3  0.11 
.4  .  0,6  0.00 
.. 
~',+/~aa;+ 
1.5  ~  18.4 
~o~  I 
.80~  O,6 
10  0  '  ........  I  ....... 
104 ~  rl0'O  I  43,5 
'~  1  I;4N  I 
.to  2  ~:, 
::  ~8.s:  4.3 
100 ~" ........ ~  ........ ;  ....... 
CD23  --  -~-  ~  --~-- 
￿9  ~  :~'I?  42.11  32[  t  t:'~;y':52:2;  .5| 
￿9 "1oO~  ....... .......... ,  ..............  ~  ￿9  ........  .... :  ........ ,  ................ 
10  ~  101  10  2  10  3  10  4  10  0  101  10  2  10  3  10  4  10  0  101  10  2  10  3  10  4 
CD22  ~  ~.  ~' 
Figure  2.  Northern blot of poly(A) + RNA from spleens of wild-type 
(+/+ ) and homozygous mutant (8T/ST) mice. (.'t) Northern blot of splenic 
poly(A) +  RNA from homozygous mutant  (ST~ST)  and control mice 
(+/+)  hybridized  with  a  C~  eDNA  and  a  8m-specific  probe.  (B) 
poly(A) + from spleens of (ST/ST) mice was sequentially hybridized with 
a C# eDNA, a 8m, a neo  r, and a C~3-specific probe. 
demonstrates that  the  3.8-,  4.0-,  and  4.8-kb  bands  also 
contain sequences derived from the neo' gene (Fig. 2 B, lane 
c), indicating that they represent aberrant splice products. The 
3.0-kb band hybridizes  with the probe specific for the C~3 
exon (Fig. 2 B, lane d) which is nonfunctional in the targeted 
allele because of frame shift mutations (44). In addition, with 
the neo  ~  probe, mKNA of 2.4 kb, which does not hybridize 
with the/~m probe, is also detected (Fig.  2 B, lanes b and 
c). Low abundant mKNAs of 1.6 and 2.0 kb hybridizing with 
a C/~m-specific  probe are detectable in 10 #g poly(A) + RNA 
from  both  normal  and  mutant  mice  (Fig.  2  A).  These 
mRNAs, however, are smaller than the normal C/~ message 
and therefore,  unlikely to encode a functional Ig molecule. 
Taken together, mRNA species representing potentially 
functional  chimeric  /~/6  molecules  are  undetectable  in 
Northern blots using as much as 10/~g of splenic poly(A) + 
RNA of ~T//~T mice. Because mRNA encoding the ~ H 
chain can be detected with the C/~m-spedfic probe in as little 
as 300 ng of poly(A)  + RNA of spleens of normal mice (Fig. 
Figure  3.  B cell maturation in IgD-defident mice. Flow cytometric anal- 
ysis of (a) lymph node and (b-d) spleen calls of wild-type mice (left, lgH', 
+/IgH  ~  + ),  and  mice  hetemzygous  (center, IgH  4,  b'T/IgH  b,  +)  or 
homozygous (right, lgH',  o'T/IgH  a, 8T) for the o1" mutation. Dots and 
numbers (%) in the fluorescence windows refer to cells in the lymphocyte 
gate as defined by light scatter (54). 
2 A), a putative mRNA encoding the extraceUular domains 
of #  and the transmembrane portion of/~ would be at least 
30-fold less abundant than 8 H chain message in normal mice, 
if it exists at all. 
IgD Deficiency  Does Not Result in a Distortion  of  Lymphocyte 
Development.  PBLs, bone marrow, peritoneum, spleen, and 
LN of heterozygous and homozygous mutant mice were ana- 
lyzed by flow cytometry to examine a possible impact from 
the absence of a functional IgD molecule on the develop- 
ment and maturation of B and/or T cells. Fig. 3 shows the 
analysis of LN and spleen cells of control (IgH',  +/IgHh 
+),  heterozygous (IgH',  #T/IgH  b,  +),  and homozygous 
mutant mice (IgH  ~, 8T/IgH', ST). Simultaneous staining 
for IgM and IgD reveals that B cells of homozygous mutant 
mice are IgD negative,  but present at normal frequency in 
LN and spleen (Fig. 3, a and b; Table 1). Whereas virtually 
all/~ + B cells from LN of normal mice express high levels 
of IgD, in IgD-deficient mice, B cells are present in LN at 
normal frequency as a/~*~-  population. Considering the 
amount of Ig expressed on the surface of B cells expressing 
the targeted or the wild-type allele, it seems that the loss 
of surface IgD is compensated by an increase in IgM expres- 
sion resulting in virtually the same level of surface Ig expressed 
48  Immunoglobulin D-deficient  Mice Table  1.  Frequency  of Cells Recovered  from Organs of Wild-type (+ / +) and Homozygous Mutant Mice (dT/t~T) 
Cell type  + / +  ~T//iT 
Bone marrow (x  107) *  2.4  _+ 0.3  (n  =  3)  2.2  •  0.1 
pre-B* (%)  15.5  •  3.0  21.7  •  11.0 
immature  B  s (%)  12.2  •  0.3  12.8  •  3.2 
mature B~ (%)  16.8  •  6.3  16.9  •  5.5 
Peritoneum  (x  l&)  3.0  •  1.0  (n  =  4)  3.8  •  2.1 
CD5 BI (%)  39.7/46.2  35.7/39.8 
PtC binding**  (%)  21.4/20.7  10.7/21.7 
Spleen(x  10  r)  9.1  •  1,7  (n  =  5)  12.4  +_ 3.0 
Bit (%)  48.9  •  5.8  (n  =  9)  46.9  +  5.1 
Tss (%)  21.9  _+ 2.2  (n  =  3)  32.2  +  4.0 
CD4/CD8 (ratio)  2.8  +  0.3  (n  ==  4)  2.1  _+ 0.7 
CD5 B (%)  <1/<1  <1/<1 
PtC binding  (%)  <1/<1  <1/<1 
(n  =  3) 
(n  =  4) 
(n  =  5) 
(n  =  9) 
(n  =  4) 
(n  =  7) 
When more than two animals were analyzed, mean and SD are given. 
* Total nucleated cells recovered. 
* CD45R/B22@o/IgM-. 
g CD45K/B22Oo/IgM  § 
II CD45R/B220hi/IgM  +  . 
￿82  CD45Rlo/CD51o. 
"* Stained with fluorescein-containing PtC-liposomes (54). 
11 IgM + and/or IgD +. 
SS Thy-1  § . 
on # +  8-  and # § (5 + B cells as determined by staining with 
an anti-x  L chain  antibody (data not  shown). 
CD22  and  CD23  are expressed on virtually  all  mature 
# +  8 + B cells, whereas immature B cells in the bone marrow 
(#+8-) lack these surface markers (52, 58, 59). Surface ex- 
pression of CD22 coinddes with that of IgD, although CD22 
seems to be expressed intracellularly early in B cell develop- 
ment (60), whereas CD23 is acquired later than IgD in on- 
togeny (58).  Spleen cells of wild-type,  heterozygous,  and 
homozygous mutant mice were stained for CD23 and CD22 
in combination with an anti-IgM antibody recognizing the 
a allotype of the targeted allele (Fig. 3, c and d). In heterozy- 
gous mutant mice that are IgH  b on the wild-type allele, the 
level of surface expression of CD22 and CD23 can be directly 
compared between #+8 + B cells  expressing the wild-type 
allele (IgM  a-) and/~+8-  B cells expressing the targeted al- 
lele (IgM'+).  The results  show that  in both heterozygous 
and homozygous mice, the latter cells express the same levels 
of the CD23 and CD22 antigens as #+8 + B cells. Thus, ex- 
pression of IgD is not a prerequisite for CD22 and CD23 
expression,  and the B cell population acquires a mature pheno- 
type in IgD-deficient mice, with respect to expression of these 
markers. 
A naturally occurring B cell population that expresses low 
levels  of surface IgD  are the  CD5  B  cells  residing  in  the 
peritoneum of normal mice (61).  A  large fraction of these 
cells  express  IgM  antibodies  binding  to  isologous  RBCs 
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pretreated with the proteolytic enzyme bromelain (62). One 
of the determinants  recognized by these antibodies is PtC, 
a membrane component exposed on senescent-  or bromelain- 
treated red blood cells (63). Using fluorescein-containing PtC 
liposomes, PtC-specific cells can be directly analyzed by flow 
cytometry (54). The data in Table 1 show a normal frequency 
of CD5 B cells and of PtC-binding cells in the peritoneum 
of 8T/~3T mice. In the spleen of 8T/8T mice, such cells are 
undetectable as they are in the controls. Thus, the 8T muta- 
tion does not affect the recruitment of B cells into the com- 
partment  of CD5  or conventional B  cells. 
The  frequency  of peripheral  T  cells  and  the  ratio  of 
CD4/CDS-positive cells in IgD-deficient mice (Table 1) was 
also found to be normal. The slight differences between con- 
trol animals and IgD-deficient mice are within the range ob- 
served  between  the  parental  strains  C57B1/6  (33%  + 
6.7% LN T cells; CD4/CD8 ratio  -- 2.0 +  0.2%) and 129 
(see Table 1,  +/+) and, therefore, most likely due to the vari- 
able genetic background of the mutant  mice. 
A Long-lived  Peripheral  B Cell  Pool  Is Established  in Ig~t 
M/c~  The majority of mature resting # +8-  B cells of an 
adult mouse is "long-lived" with a half-life of several weeks 
or months (55). To examine the life span of peripheral B cells 
in homozygous ST~ST mice, we measured BrdU incorpora- 
tion into spleen cells of mice fed for 6 d with BrdU in the 
drinking water.  The result (Fig. 4) shows the same degree 
of labding of splenic B calls in homozygous mutant (ST//~T) +/+  6T/8"r 
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Figu~  4.  B cell life span in IgD-deficient mice. Spleen cells of wild- 
type (+/+ ) and homozygous mutant mice (~T/ST) fed for 6 d with 1 
mg BrdU per ml drinking water (left and center) were analyzed by flow 
cytometry for BrdU incorporation. (Right) Unlabeled control. The numbers 
in  the upper right  quadrant  are  percent of B  cells  (CD45R/B220 +) 
staining with the anti-BrdU antibody. Each number refers to one individual 
mouse. 
and wild type (+/+) animals, indicating that expression of 
IgD is not required for establishing the long-lived peripheral 
B cell pool of an adult mouse. 
/.z +~-  B  Cells Expressing  the  Targeted Allele Are  Under- 
represented in Heterozygous Mutant Mice.  Comparison of the 
frequency of B ceils expressing the targeted or the wild type 
allele in mice heterozygous for the/~T mutation reveals an 
underrepresentation of B calls expressing the targeted allde 
(Fig. 3; Table 2). This underrepresentation, observed in PBLs 
as well as splenic B cells, indicates that B cells expressing the 
wild type allele have an advantage in populating the periph- 
eral B cdl pool over the/~+~-  population. This becomes 
apparent only in the case of competition between #+b- 
and/~+/~+ B cdls in heterozygous mutant mice. In homozy- 
Table  2.  Frequency (percent) of B  Cells Expressing  the IgH" or 
Igl-1  s Allele in  Wild-type  FI (IgI-P, + /IgH*, +) and Heterozygous 
Mutant F, (IgH*,6T/IgH b, +) Mice at 3 or 6 Mo of Age 
IgH  =, +/IgH b, +  IgH',ST/IgH  b, + 
PBL 
3 mo 
6  mo 
Spleen 
3  mo 
16.1"/13.7'  11.9  _+  0.8/17.0  _+  1.9  (n  =  5) 
1.18S  0.7  +  0.06 
15.9/14.6 
1.09 
10.0/10.9  13.6  +  4.1/22.5  +  5.1  (n  =  3) 
0.92  0.59  +  0.06 
16.4/14.0 
1.17 
23.2/23.4  16.6/22.1 
0.99  0.75 
When more than two animals were analyzed, mean and SD are given. 
* Percent B cells expressing the IgH= allele (/~=+ and/or 6 +). 
Percent B cells expressing the IgH  b allele (/~h.  and/or 8b+). 
S percent lgH  ~ divided by percent IgH  b. 
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Figure  5.  Serum lg isotypes in IgD-deficient mice. (a) Concentration 
(#g/ml) of Ig isotypes in sera of 10-wk-old homozygous mutant (closed 
circles) and 13-wk-old control animals (open circles) and (b) in sera obtained 
from 6-too-old animals. 
gous mutant mice, in the absence of competing #+#+  B 
cells, #+/~-  B cells are present in normal numbers (Table 1; 
Fig.  3). 
Serum Ig in IgD-deficient Mice.  Serum Ig isotype levels of 
10-wk- and 6-too-old homozygous mutant and wild-type mice 
are shown in Fig. 5, a and b. Igs of the various isotypes ex- 
cept IgE are present in homozygous mutant mice at levels 
equal or dose to those of controls. The lower level of IgG2a 
in 10-wbold mutant mice compared with 13-wk-old con- 
trols (Fig. 5 a) could be due to the age diff~ce of the animals. 
IgG2a levels were the same in 6-too-old homozygous mu- 
tant and control mice (Fig. 5 b). It is interesting, however, 
that the IgE levds were lower in IgD-deficient than control 
mice at both time points. This may indicate that triggering 
of B cells by antigens that elicit  an IgE response of IgD- 
deficient  mice) is less effective in IgD-deficient mice. 
IgD-deficient Mice Respond E~ciently to TI-II Antigens.  We 
investigated the immune responsiveness of IgD-ddicient mice 
to the TI-II antigens c~(1-3)-dextran and NP-Fico11. The re- 
sponse to ~(1-3)-dextran of IgH' aUotype mice is dominated 
by ht L chain-bearing antibodies and appears largely derived 
from CD5 B ceils, whereas the anti-NP response originates 
from conventional B calls (51). The results are shown in Fig. 
6. It is evident that IgD-deficient mice are capable of mounting 
efficient immune responses  against TI-II antigens. 
IgD-def~ient Mice Restnnut to T Cell-dependent Ana'gen.  Fig. 
7 shows that the levels of antigen-specific Ig in primary and 
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Figure 6.  Immune response of ~iT/b'T  mice to TI-II antigens. (a) c~-(1-3)- 
dextran-specific IgM or X-bearing antibody titers in (preimmune and im- 
mune) sen obtained 7 d after immunization. (b) NlXspecitic IgM and lgG3 
in sera obtained at day 10 after immunization with NP-HCOU. (Open circles) 
controls. (Closed circles) 6T/rT. 
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Figure  7.  Serum concentrations ofhapten (N  O- and carrier (CG)-specific 
antibodies of ST/ST (closed circles) and control mice (open circles) immunized 
with NP-CG. (a) Primary response day 6; (b) primary response day 14; 
and (c) secondary response day 6. NP-specific, as well as CG-spedfic  titers 
are given relative to anti-NP mAbs of the various isotypes used as stan- 
dards.  1 unit corresponds to ~ol/~g. 
secondary responses of IgD-ddicient mice to the TD antigen 
NP-CG reach those of control mice; only at day 6 are lower 
CG-specific titers observed in IgD-deficient mice (Fig.  7 a). 
This may reflect a ddayed onset of the carrier-specific response 
in IgD-deficient compared  with control mice. 
de;.~nitl/ Maturation of Serum Antibodies Is Delayed in IgD- 
cient Mio~  Relative  a~nities of serum antibodies  were 
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Figure  8.  Affinity maturation ofanti-NP IgG1 in sera oflgD-daficient 
and control mice. 4-5 mice per group were immunized with 10 (a), 20 
(b), or 100/~g NP-CG (c) and NP-specific IgG1 titers and affinities of NP- 
specific IgG1 were determined at the time points indicated. (d) NlXspecitlc 
IgG1 and affinities in sera obtained on day 6 after a second injection of 
NP-CG. (B6  x  129)Pz (IgH'/IgH,) (b, open squares) or 129/sv (a and c) 
mice were used as controls (open circles). (Closed circles) ST/ST. 
determined using a plate binding assay that is based on the 
correlation of the affinity constant with the relative binding 
of antibodies to coats of low and high epitope densities (36). 
This assay offers a sensitive test to compare relative affinities 
of serum antibodies, and standardization  using mAbs of known 
affinity allows an indirect measurement of the average affinity 
of serum antibodies  in a first approximation. Fig. 8 shows 
titers of NP-specific  IgG1 (top) and the corresponding ratios 
of NP-binding at low and high hapten density as a relative 
measurement of antibody affinity (bottom) in immune sera 
obtained at different time points after primary (Hg. 8, a-c) 
and secondary immunization (Fig. 8 d). In the control groups 
as well as in IgD-delicient mice, binding ratios of NP-specific 
IgG1 increase, indicating affinity maturation in the course 
of the primary response. Furthermore, virtually the same level 
of affinity is reached in secondary response sera of wild-type 
and IgD-deficient mice. It is interesting,  however, that when 
comparing the responses  of both groups at  a given  time 
point-although the level and kinetics of IgG1 production 
by IgD-deficient mice are the same as that of the controls- a 
significantly lower binding ratio of primary response IgG1 
in IgD-deficient mice is consistently observed in three inde- 
pendent experiments using different doses of antigen and in- 
cluding mice of different genetic background (Fig.  8, a--c). 
Although the differences in affinity are not dramatic, it would 
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Figure  9.  NF-specific IgG1 datival from the targeted al- 
lele is undm'~ented in h~eroz~ous mutant mice. Shown 
is  the anti-Nl~CG  response  of (a)  (B6  ￿  129)F1 (IgH,, 
+/IgH  b,  +) control and (b) (136 x  129)F1 (IgH~, 5T/IgH  b, 
+) heterozygous  mutant mice [(closed circles) IgGl*; (open 
circles) IgGlb;  and (open squares)  total  IgG1].  (c) Ratio of 
IgGlo/IgG1 b of control F1 (open triangles) and heterozygous 
mutant F1 mice (dosed triangles).  Hve mice per group were 
immunized with 100 pg NP-CG,  and titers of NP-specific 
IgG1 in ~ra obtained at the time points indicated are given 
as geometric  mean  •  SD. appear that the early primary IgG1 response (of IgD-deficient 
mice) is less effective than that of IgD-competent animals, 
because affinity maturation, i.e., production of high affinity 
antibodies, is delayed by 3-4 d (Fig. 8, a-c), imposing a pos- 
sibly critical disadvantage on IgD-deficient mice in the de- 
fense against pathogens. 
/~+d + B Cells Are Preferentially Recruited into the T  cell- 
dependent Immune Response in Heterozygous Mutant Mice  The 
analysis of mice heterozygous  for the ST mutation allows 
a direct comparison of the relative contribution to the anti 
NP-CG response of B cells expressing the targeted allele and 
B cells expressing the wild type allele. Fig. 9 shows NP-specific 
IgG1  derived  from  either  allele  in  control  Ft  (IgH  ~, 
+/IgH  b,  +)  and  heterozygous  mutant  F1  mice  (IgH', 
6T/IgH  b,  +), measured at various time points after immu- 
nization. The amount of NP-specific IgG1 derived from the 
a allele and the b allele is similar in control F1 mice, resulting 
in  a  ratio  of  the  geometric  mean  values  of  1.18 for 
IgGlfflgG1  b (416/352  #g/ml)  at day  10 of the response 
(Fig. 9 c). In contrast,  a ratio of 0.23  (148/643  #g/ml) is 
observed in heterozygous mutant mice beating the/~T muta- 
tion on the IgH  ~ allele. This results from a reduction of NP- 
specific IgGl~-derived from the targeted allele, accompanied 
by a compensatory increase in NP-specific IgG1  b produced 
by B cells expressing the wild type allele. 
Discussion 
Gene Targeting Technology Provides a Tool to Directly Assess 
the Role of lgD In Viva  Experiments conducted in the past 
to assess the biological role of IgD in B cell development 
were largely based on the sdective removal of IgD from the 
B ceil surface by treatment with proteolytic enzymes or anti- 
IgD antibodies in vivo or in vitro. The results, however, were 
contradictory and a consistent picture did not emerge (13, 
22, 23, 25-30). This may be partly due to the fact that these 
experimental approaches involved proteolytic digestion of sur- 
face proteins, likely to affect surface proteins other than IgD 
on the one hand, and to be incomplete on the other, or that 
engagement of surface Ig which -  apart from removing IgD 
-  might alter the activation state of the B cell. The disrup- 
tion of the C6 gene in the mouse germline allows a more 
direct investigation of the biological role of IgD. Extending 
our previous observations  (44), the present resuks exclude 
an essential role for IgD in B cell development and matura- 
tion, and suggest that the major function of IgD resides in 
its capacity to improve the efficiency of the early antibody 
response. 
Models Assigning to IgD a Major and Unique Regulatory Func- 
tion  Are  Not  Supported by  the  Phenotype of IgD-deficient 
MIC~  The fact that IgD-deficient mice respond to TI-II and 
TD antigens rules out a critical role for IgD in the acquisi- 
tion of immune responsiveness. Thus, modds proposing IgD 
as an essential triggering receptor in general (22-24)  or for 
the activation of B cells by TI-II (25) or TD (26) antigens 
do not gain support from the analysis of IgD-deficient mice. 
Furthermore, an important role for IgD in maintaining B 
cell tolerance (42) is called into question, because IgD-defident 
mice do not develop any obvious symptoms of autoimmunity. 
IgD As an  Optimized  Surface Receptor Improving B  Cell 
Recruitment by Antigen.  The analysis of heterozygous mu- 
tant mice allows a direct comparison within the same animal 
of the effect of the ST mutation, because in these animals 
#+6 + and #+/~-  B cells compete with each other. We have 
previously  shown  that  the  peripheral  pool  of bng-lived 
/z +  6 + cells in normal mice is strongly sdected for the dom- 
inant expression of certain antibody specificities and have in- 
terpreted this as antigen-driven B cell sdection (64). In the 
heterozygous mutant mice, the IgD-deficient B cells are losers 
in this competition in that they are underrepresented in com- 
parison with their IgD-positive counterparts  (Table 2). Simi- 
larly, lower levels of IgG1 are produced in these animals from 
the targeted allde in the primary response to NP-CG, ac- 
companied by a compensatory increase of IgG1 produced by 
B cells expressing the wild-type allele (Fig. 9). This likely 
reflects more efficient recruitment of the latter ceils into the 
response rather than simply their more abundant occurrence 
in the peripheral pool, because the difference in response is 
fivefold at day 10 compared with a 1.5-fold difference in pool 
size (Table 2; Fig. 9). It thus appears that IgD facilitates B 
cell recruitment into certain differentiation  pathways. This 
is also and perhaps most strikingly observed at the level of 
affinity maturation in the early TD primary response as dis- 
cussed below. 
It is tempting to speculate that IgD may represent a par- 
ticularly effident antigen-binding receptor because  of its unique 
structural flexibility. This is conferred on the molecule by 
an extended hinge region. Additionally, the H chains of the 
dimeric receptor are covalently linked by ouly one disulfide 
bridge dose to the carboxy terminus. These structural char- 
acteristics allow for a higher degree of freedom of the an- 
tigen binding sites than observed for other Ig isotypes (8). 
The role of hinge regions in generating flexibility of Ig mol- 
ecules, facilitating antigen binding has been established (65), 
and the high degree of susceptibility  to proteolysis of IgD 
may be merely a consequence of its flexibility (65), rather 
than being of functional importance per se (24, 45). Because 
of its flexibility, IgD would allow more efficient binding of 
multimeric antigen than the more rigid IgM, in that it would 
more easily bind target epitopes with both V domains simul- 
taneously. Receptor occupancy could be further increased if 
both antigen binding sites were able to move independently 
of each other as "half molecules" (H1/L1). Significantly, the 
existence of IgD half molecules (H1/L1) in equilibrium with 
monomers on the B cell surface has been demonstrated (66, 
67). in light of these data, IgD could be regarded as an op- 
timized surface  antigen receptor allowing high-avidity binding 
orB calls to antigen presented in multimeric form, e.g., any 
antigen displayed on the surface of APCs. 
A  Role for IgD in Affinity Maturation of the Antibody Re- 
sponse.  Affinity maturation and the establishment  of high 
affinity B cell memory is apparently  taking place in IgD- 
deficient mice, but affinity maturation is delayed compared 
to wild-type animals (Fig. 8). Although reservations may have 
52  Immunoglobulin D-deficient Mice to be placed on the precision of a plate binding assay in deter- 
mining absolute affinities, the data dearly show a reduced 
capability to trap antigen and a delayed maturation of serum 
antibodies in the early primary response of IgD-deficient mice 
compared to controls. Additional support to the significance 
of the data is provided by the fact that no differences  in binding 
ratios of anti-NP IgG antibodies elicited by the TI hapten 
conjugate NP-Ficoll were observed between wild-type and 
IgD-deficient mice (data  not shown). 
Because affinity maturation through hypermutation occurs 
in germinal centers (68, 69) where IgD is downregulated in 
the proliferating B cells (2, 70), it is likely that IgD affects 
the efficiency of affinity maturation in a similar way as dis- 
cussed above, namely at the stage of recruitment of the cells 
into this particular differentiation pathway. It is not obvious 
why this effect should be more apparent at the level of affinity 
maturation than at the level of antibody production and ki- 
netics of the primary anti-NP response which appears to be 
similar in IgD-deficient mice and controls (Figs.  8 and 9; 
and data not shown). This seems in contrast to the advan- 
tage orB cells expressing the wild-type IgH locus in the pri- 
mary response to NP-CG in heterozygous mutant mice (Fig. 
9 and previous section). The latter phenomenon, however, 
could well be due to a more efficient affinity maturation in 
the wild type cells, which would further support a particular 
role for IgD in the recruitment of B cells into the germinal 
center response. For technical reasons we have not been able 
to determine allotype-specific affinities in heterozygous mice. 
Perhaps B cells are recruited into the germinal center at 
a time when antigen becomes limiting and/or through the 
recognition of antigen-antibody complexes on the surface 
of APCs. In both cases, the flexibility of surface IgD may 
be particularly important for the B cell to efficiently interact 
with antigen and perhaps with the cell presenting it. The 
alternative possibility, namely that a signal delivered through 
IgD is required to recruit B cells into germinal centers is ex- 
cluded not only because of the results of Vonderheide and 
Hunt (71), but also because we have observed substantial 
numbers of histologically normal germinal centers in the 
spleens of IgD-deficient mice (unpublished data). 
Finally, it should be pointed out that despite the occur- 
rence of germinal centers in IgD-deficient mice and the ability 
of these animals to produce high affinity secondary response 
antibodies that are indistinguishable from those of control 
mice (Fig. 8 d), we cannot formally rule out at this point 
that in the absence of surface IgD the hypermutation mecha- 
nism operating on rearranged V region genes in germinal 
centers (68, 69) is not turned on. Although this possibility 
seems remote in light of the evidence that affinity matura- 
tion in 2~ chain-bearing anti-NP antibodies is due largely, if 
not exclusively, to somatic hypermutation rather than the 
outgrowth of preexisting, rare, high affinity clones, as was 
shown for antibodies of the b allotype (72) sequence analysis 
of rearranged antibody V  region genes from the mutant 
animals, is required to definitively settle this point. Such an 
analysis is presently underway. 
Our data indicate that the unique function of IgD is that 
of an auxiliary surface-bound antigen receptor. This is in line 
with the earlier work of Pur~ and Vitetta who reported that 
surface expression of IgD facilitated the response to antigens 
of low epitope density in vitro (38).  IgD would mediate 
efficient interaction of B cells with their target antigens, and 
perhaps also with Th cells through IgD-binding receptor mol- 
ecules (40, 41). The principle of dual isotype expression may 
have allowed an evolutionary optimization of the IgD mole- 
cule for serving this function, whereas IgM would be free 
to be optimized to efficiently mediate effector functions in 
the early humoral response. 
In the initiation of the germinal center response, the con- 
tribution oflgD to B cell recruitment appears to be particu- 
larly important. Once driven into this differentiation pathway, 
the cells downregulate surface IgD with its presumed high 
avidity for antigen complexed on the membrane of follicular 
dendritic cells, allowing stringent selection orB cells expressing 
high affinity  antibodies. 
Although the difference in antibody affinities between con- 
trol animals and IgD-deficient mice in the course of the early 
primary TD response are only moderate, it would seem from 
the data in Fig. 8 that in the mutant mice, affinity matura- 
tion, i.e.,  the production of antibodies of high affinity, is 
delayed by 3-4 d as compared with the controls. Thus, ex- 
pression of IgD could confer a critical advantage in the de- 
f~mse against pathogens undergoing rapid expansion and muta- 
tional drift upon entry into the host. 
We are grateful to Drs. A. Kantor, J. Kearney, R. M. E. Parkhouse, R. Tortes, W. Miiller, and Genetics 
Institute, Cambridge, MA for reagents; D. Kitamura, R. Kiihn, W. Mtiller, and S. Taki for discussions; 
C. Uthoff-Hachenberg for technical  help; I2. Ringeisen for the graphical work; and R. Tortes for critical 
reading of the manuscript. 
This work was supported by the Deutsche Forschungsgemeinschaft  (SFB243), the Human Frontier Science 
Program Organisation, and the Fazit Foundation. J. Roes was supported by a stipend from the Fonds 
der Chemie. 
Address  correspondence  to J0.rgen Roes, Institute for Genetics, University  of Cologne, Weyertal 121, D-5000 
K61n 41, FRG. 
Received for publication 13Ju[2/1992  and in revised  form 18 September 1992. 
53  Rots and gajewsky References 
1.  Rowe, D.S., K. Hug, L. Forni, and B. Pernis. 1973. Immuno- 
globulin D as lymphocyte receptor. J. Ex  F  Med.  138:965. 
2.  Martin, L.N., and G.A. Leslie. 1977. Lymphocyte  surface  IgD 
and IgM in macaca  monkeys:  ontogeny tissue distribution and 
occurrence on individual lymphocytes. Iramunol. 33:865. 
3.  Abney,  E.K., and K.M.E. Parkliouse. 1974. Candidate for im- 
munoglobulin D present on murine B lymphocytes. Nature 
(Lond.). 253:600. 
4.  Melcber, U., E,S. Vitetta, M. McWilliams,  M.E. Lamm, J.M. 
pliillips-Quagliata, and J.W. Uhr. 1974. Cell surface  immuno- 
globulin X. Identification of  an IgD-like molecule on the sur- 
face of routine sphnocytes. J. Ex  F  Med.  140:1427. 
5.  Ruddik, J.H., and G,A. Leslie. 1977, Structure and biologic 
function of human IgD. XI. Identification and ontogeny of 
a rat  lymphocyte immunoglobulin  having antigenic cross- 
reactivity with human IgD. J. Immunol.  118:1025. 
6.  Eskinazi, D.P., B.A. Bessinger,  J.M. McNicholas, A.L. lear/, 
and K.L. Knight. 1979. Expression of an unidentified immu- 
noglobulin isotype on rabbit Ig-bearing lymphocytes.  J. Im- 
munol. 122:469. 
7.  Wilder, K.L., C.Y. Yuen, S.A. Coyle, and K.G. Mage. 1979. 
Demonstration of  a rabbit cell surface  Ig that bears light chain 
and V,, but lacks #-, or-, and 3,-allotypes - rabbit IgD? J. Im- 
raunol. 122:464. 
8.  Blattner, F.R., and P.W. Tucker. 1984. The molecular biology 
of immunoglobulin D. Nature (Lond.). 307:417. 
9.  Vitetta, E.S., and J.W. Uhr. 1977. IgD and B cell differentia- 
tion. ImmunoL  Rev. 37:50. 
10.  Goding, J.W., D.W. Scott, and J.E. Layton. 1977. Genetics, 
cellular expression and function of IgD and IgM receptors. 
Immunol.  Rev. 37:152. 
11.  Havran, W.L., DiGiusto,  D.L.,  and J.C.  Cambier. 1984. 
mlgM:mlgD ratios on B cells: mean mlgD expression  exceeds 
mlgM by 10-fold  on most splenic  B cells.J. Iraraunol. 132:1712. 
12.  Abney, E.K., M.D. Cooper, J.F. Kearney, A.K. Lawton, and 
K.M.E. Parkhouse. 1978. Sequential expression of immuno- 
globulin on developing mouse B lympbocytes. A systematic 
survey  which suggests a model for the generation ofimmuno- 
globulin isotype diversity,  J. Iramunol.  120:2041. 
13.  Layton, J.E., G.K. Johnson, D.W. Scott, and G.J.V. Nossal. 
1978. The anti delta suppressed mouse. Eur.J. Imraunol. 8:325. 
14.  Sieckmann, D.G., F.D. Finkelman, and I. Scher. 1982. IgD as 
a receptor in signaling the proliferation of mouse B-lympho- 
cytes. Ann.  NY Acad. Sci. 399:277. 
15.  Cambier,  J.C., L.B.  Justement, M.K. Newell, Z.Z. Chen, L.K. 
Harris, V.M. Sandoval, M.J, Klemsz, andJ.T. Ransom. 1987. 
Transmembrane signals and intracellular "second messengers" 
in the regulation of quiescent B-lymphocyte activation. Im- 
raunol. Rev. 95:37. 
16.  Bourgois, A., K. Kitasima, I.R. Hunter, and B.A. Askonas. 
1977. Surface immunoglobulin of lipopolysaccharide stimu- 
lated spleen cells -  The behaviour of IgM, IgD, and IgG. 
Eur. J. Immunol.  7:151. 
17.  Monroe, J.G., W.L. Havran, and J.C. Cambier. 1983. B lym- 
phocyte activation: entry into cell cycle  is accompanied  by de- 
creased expression  of IgD but not IgM. Eur.J. Iramunol. 13:208. 
18.  Kocks, C., and K. Rajewsky, 1989. Stable expression and so- 
matic hypermutation of antibody V regions in B cell develop- 
mental pathways. Annu.  Rev. Immunol.  7:537. 
19.  Rowe,  D.S., and J.L. Fahey. 1965. A new class of human im- 
munoglobulins. I. A unique myeloma protein. J. EXlX Med. 
121:171. 
54  Immunoglobulin  D-deficient Mice 
20.  Nossal, GJ.V., and KL. Pike. 1975. Evidence for the clonal 
abortion theory of  B lymphocyte  tolennce.J. Ex/t Med. 141:904. 
21.  Metcalf, E.S., and N.K. Klinman. 1976. In vitro tolerance in- 
duction of neonatal murine B cells.  J. ExI~ Med.  143:1327. 
22.  Cambier, J.C., E.S. Vitetta, J.K. Kettman, G.M. Wetzel, and 
J.W. Uhr. 1977. B cell tolerance. III. Effect  of  papain-mediated 
cleavage of cell surface IgD on tolerance susceptibility of mu- 
rine B cells.  J. Ex  F  Med.  146:107. 
23.  Scott, D.W.,  J.E. Layton, and G.J.V. Nossal. 1977. Role oflgD 
in the immune response and tolerance. I. Anti-delta pretreat- 
ment facilitates tolerance induction in adult B cells in vitro. 
J. Ex  F  Med.  146:1473. 
24. Vitetta, E.S., and J.W. Uhr. 1975. Immunoglobulin receptors 
revisited. Science (Wash. DC).  189:964. 
25.  Zitron, I.M., D.E. Mosier, and W.E. Paul. 1977. The role of 
surface IgD in the response to thymic-independent antigens. 
J. Exlx Med.  146:1707. 
26. Cambier, J.C., F.S. Ligler, J.W. Uhr, J.R. Kettman, and E.S. 
Vitetta. 1978. Blocking of a primary in vitro antibody responses 
to thymus-independent and thymus-dependent antigens with 
antiserum specific  for IgM and IgD. Proc Natl. Acad. Sci. USA. 
75:432. 
27. Jacobson, E.B., Y. Baine, Y.W. Chert, B. Petals, G.W. Siskind, 
and GJ. Thorbecke. 1982. Effect of Allotype Specific Anti- 
IgD on the Immune Responses of Heterozygous Mice. Ann. 
NY Acad. Sci. 399:340. 
28. Leslie,  G.A., and M.A. Cuchens. 1982. Developmental  aspects 
of rat IgD expression and the consequences of IgD modula- 
tion. Ann.  NY Acad. Sci. 399:131. 
29.  Bazin, H., B. Plattean, A. Beckers, and R. Pauwels. 1978. 
Differential effect of neonatal injections of anti-1 or anti-d an- 
tibodies in the synthesis oflgM, IgD, IgE, IgA, IgG1, IgG2a, 
IgG2b,  and  IgG2c  immunoglobulin  classes. J.  Iraraunot. 
121:2083. 
30.  Mosier, D.E., I.M. Zitron, J.J. Mond, A. Ahmed, I. Scher, 
and W.E. Paul. 1977. Surface Immunoglobulin D as a func- 
tional receptor for a subclass orb lymphocytes. ImraunoL Rev. 
37:89. 
31. Tisch,  tL., C.M. Roifman, and N. Hozumi. 1988. Functional 
differences between IgM and IgD expressed on the surface of 
an immature B-cell line. Proc. Natl. Acad. Sci. USA. 85:6914. 
32.  Ales-Martinez,  J.E., G.L. Warner, and D. Scott. 1988. Immu- 
noglobulins D and M mediate signals that are qualitatively 
different in B cells with an immature phenotype. Proc Natl. 
Acad. Sci. USA.  85:6919. 
33. Kim, K.M., T. Ishigami, D. Hata, Y. Higaki, M. Morita, K. 
Yamoaka, M. Mayumi, and H. Mikawa. 1992. Anti-IgM but 
not anti-IgD antibodies inhibit cell division of normal human 
mature B cells.  J. Iraraunol. 148:29. 
34.  Zan-Bar, I., S. Strober, and E.S. Vitetta. 1979. The relation- 
ship between surface immunoglobulin isotype and immune 
function of routine B lymphocytes. IV. Role of IgD-bearing 
cells in the propagation of immunologic memory.J. Iramunol. 
123:925. 
35. Black,  S.J., T. Tokuhisa, L.A. Herzenberg, and L.A. Herzen- 
berg. 1980. Memory B cells at successive stages of differentia- 
tion: expression of surface IgD and capacity for self renewal. 
Fur. j. Imraunol.  10:846. 
36. Herzenberg, L.A., S.J. Black, T. Tokuhisa, and L.A. Herzen- 
berg. 1980. Memory B ceils  at successive  stages of  B cell  differen- 
tiation; affinity maturation and the role of IgD receptors.  J. 
EXlX Med.  151:1071. 37.  M6iler, G., M. Alarcon-Riquelme, B. Clinchy, C.M. Gontijo, 
and I. H6iden. 1991, The immunoglobulin receptors on B ceils 
bind antigen, focus activation signals to them and initiate an- 
tigen presentation. Scand, f  Iraraunol. 33:111. 
38.  Pure, E., and E.S. Vitetta. 1980. The murine B cell response 
to TNP-polyacrylamide beads: The relationship between the 
epitope density of the antigen and the requirements for T ceLl 
help and surface IgD. f  Iraraunol. 125:420. 
39.  Cheng, H.-L., F.R. Blattner, L. Fitzmaurice,  J.F. Mushinsky, 
and P.W. Tucker. 1982. Structure of genes for membrane and 
secreted raurine IgD heavy chains. Nature (Land.). 296:410. 
40.  Coico, R.F., G.W. Siskind, and G.J. Thorbecke. 1988. Role 
of IgD and T/~ cells in the regulation of the humoral immune 
response. Imraunol. Rev. 105:45. 
41.  Amin, A.R., S.M. Tamma,  J.D. Oppenheim, F.D. Finkelman, 
C. Kieda, R.F. Coico, and G.J. Thorbecke. 1991. Specificity 
of the routine IgD receptor on T cells is for N-linked glycans 
on IgD molecules. Pro~ Natl. Acad. Sci. USA. 88:2938. 
42.  Goodnow,  C.C., J. Crosbie,  J. Adelstein,  T.B. Lavoie,  S.J. Smith- 
Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wotherspoon, 
R.H. Loblay, K. Raphael et al. 1988. Altered immunoglob- 
ulin expression and functional silencing of self-reactive  B lym- 
phocytes in transgenic mice. Nature (Land.). 334:676. 
43.  Hayakawa, K., R.R. Hardy, D.R. Parks, and L.A. Herzen- 
berg. 1983. The "Ly-1 B" cell subpopuhtion in normal, im- 
munodefective and autoimmune mice.f Exp Med. 157:202. 
44.  Roes,  J., and K. Rajewsky. 1991. Cell autonomous expression 
of IgD is not essential for the maturation of conventional B 
cells. Int. Immunol. 3:1367. 
45.  Bourgois, A.,  E.R. Abney, and R.M.E.  Parkhouse. 1977. 
Mouse  Immunoglobulin  receptors on  lymphocytes: iden- 
tification of IgMs and IgD molecules by tryptic cleavage and 
a postulated role for cell surface IgD. Fur.  J. lmraunol. 7:210. 
46.  Kfihn, R., K. Rajewsky,  and W. Mfiller. 1991. Generation and 
analysis of interleukin-4 deficient mice. Science (Wash. DC). 
239:487. 
47.  Richards, J.E., A.C. Gilliam, A. Shen, P.W. Tucker, and ER. 
Bhttner. 1983. Unusual sequences in the routine immunoglob- 
ulin #-/~ heavy chain region. Nature (Lond.), 306:483. 
48.  Sambrook, J., E.F. Fritsch, and T. Maniatis. 1989. Molecular 
cloning. A Laboratory Manual. 2nd ed. Cold Spring Harbor 
Laboratory, Cold Spring Harbor, NY. 
49.  Thomas, K.R., and M.R. Capecchi. 1987. Site-directed  muta- 
genesis by gene targeting in mouse embryo-derived  stem cells. 
Ceil. 51:503. 
50. Kitamura,  D.,  J. Roes,  R. Kfihn,  and K. Rajewsky.  1991.  A 
B ceil-deficient  mouse by targeted disruption of the membrane 
exon of the immunoglobulin #  chain gene. Nature (Lond.). 
350:423. 
51.  P6rster, I., and K. Rajewsky. 1987. Expansion and functional 
activity of Lyl  § B cells upon transfer of peritoneal ceils into 
allotype-congenic, newborn mice. Fur. f  Immunol. 17:521. 
52.  Torres,  R.M., C.-L. Law,  L. Santos-Argumendo,  P.A, Kirkham, 
K.  Grabstein, R.M.E.  Parkhouse, and  E.A.  Clark.  1992. 
Identification and charactcrisation of the murine homologue 
of CD22, a B lymphocyte-restricted  adhesion molecule.f Im- 
munol. 49:2441. 
53.  Lanier, L.L., G.A. Gutman, D.E. Lewis, S.T. Griswold, and 
N.L. Warner. 1982. Monoclonal antibodies against rat immu- 
noglobulin kappa light chains. Hybridoraa. 1:125. 
54.  Mercolino, T.J., L.W. Arnold,  L.A.  Hawkins,  and  G. 
Haughton. 1988. Normal mouse peritoneum contains a large 
population  of Ly-1  §  (CDS)  B  cells that  recognize phos- 
phatidylcholine. Relationship to cells that secrete hemolytic 
antibody specific for autologous erythrocytes. J.  Exlz  Ailed. 
168:687. 
55.  F6rster, I., and K. Rajcwsky. 1990. The bulk of the peripheral 
B-cell pool in mice is stable and not rapidly renewed from the 
bone marrow. Proc Natl. Acad. Sci. USA.  87:4781. 
56.  Cumano, A., and K. Rajcwsky. 1985. Structure of primary 
anti-(4-hydroxy-3-nitrophenyl)acetyl  (NP) antibodies  in normal 
and idiotypically suppressed C57B1/6 mice. Fur. J. Immunol. 
15:512. 
57. Alt, F.W., A.L.M. Bothwell, M. Knapp, E. Siden, E. Mather, 
M. Koshland, and D. Baltimore. 1980. Synthesis of secreted 
and membrane-bound immunoglobulin mu heavy chains is 
directed by mRNAs that differ at their Y-ends. Cell. 20:293. 
58.  Waldschmidt, T.J., D.H. Conrad, and R.G. Lynch. 1988. The 
expression of  B cell surface  receptors. I. The ontogeny and dis- 
tribution  of the routine B cell IgE Fc receptor. J. Immunol. 
140:2148. 
59.  Waldschmidt,  TJ., F.G.M. Kroese,  L.T. Tygrett, D.H. Conrad, 
and R.G. Lynch. 1991. The expression orB cell surface  receptors. 
III. The murine low-affinity IgE l~c receptor is not expressed 
on Ly 1 or "Ly l-like" B cells. Int. Imrnunol. 3:305. 
60. DSrken, B., A. Tezutto, M. KShler, E. Thid, and W. Hun- 
stein. 1987. Expression  of  cytoplasmic  CD22 in B-cell  ontogeny. 
In Leukocyte  Typing III. White Cell Differentiation Antigens. 
A.J. McMichael, editor. Oxford  University Press, Oxford. 
474-476. 
61.  Herzenberg, L.A., A.M. Stall, P.A. Lalor, C. Sidman, W.A. 
Moore, D.R. Parks, and L.A. Herzenberg. 1986. The Ly-1 B 
cell lineage. Immunol. Rev. 93:81. 
62. Hayakawa, K., R.K. Hardy, M. Honda, L.A.  Herzenberg, 
A.D. Steinberg,  and  L.A.  Herzcnberg.  1984.  Ly-1  B cells:  func- 
tionally  distinct  lyrnphocytes  that  secrete  IgM autoantibodies. 
Proc Natl. Acad. Sci. USA.  81:2494. 
63.  Cox, K.O., and S.J. Hardy. 1985. Autoantibodies  against  mouse 
bromelain-modified  RBC are specificaLly  inhibited  by a common 
membrane phospholipid, phosphatidylcholine. Immunol. 55: 
263. 
64.  Gu, H., D. Tarlinton, W. M~Ller,  K. Rajewsky,  and I. FSrster. 
1991. Most peripheral B ceils in mice are ligand selected.  J. 
EXla Med. 173:1357. 
65.  Netzlin, R. 1990. Internal movements  in immunoglobulin  mol- 
ecules. Adg Immunol. 48:1. 
66.  Eidels, L. 1979. IgD is present on the ceil surface of murine 
lyrnphocytes  in two forms: ~2L2 and ~L.J. Iraraunol. 123:891. 
67.  Mescher,  M., and R.R. Pollack. 1979. Murine ceLl  surface  im- 
munoglobulin:  two  forms  of ~heavy chain..J.  Iraraunol. 
123:1155. 
68.  Berek, C., A. Berger, and M. Apel. 1991. Maturation of the 
immune response in germinal centers. Cell. 67:1121, 
69. Jacob, J., G. Kelsoe, K. Rajewsky, and U. Weiss. 1991. In- 
traclonal generation of antibody mutants in germinal centers. 
Nature (Land.). 354:389. 
70.  Kroese, F.G.M., W. Timens, and P. Nieuwenhuis. 1990. Ger- 
minal  center reaction and B lymphocytes:  morphology  and func- 
tion.  Cu~  ToI~ Pathol. 84:103. 
71. Vonderheide, R.H., and S.V. Hunt.  1991. Comparison of 
IgD + and IgD-  thoracic duct B lymphocytes as germinal 
center precursor ceils in the rat. Int. Immunol. 3:1273. 
72.  Allen, D.,  T.  Simon,  F.  Sablitzky, K.  Rajewsky, and A. 
Cumano. 1988. Antibody engineering  for the analysis  of  affinity 
maturation of  an anti-hapten response. EMBO (Fur. Mol. Biol. 
Organ.)f  7:1995. Corrigendum.  8:2444. 
55  Noes and Rajewsky 